3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 3.600
-0.140 (-3.74%)
May 28, 2026, 4:08 PM HKT
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 917.74 million as of May 28, 2026. Its market cap has increased by 18.93% in one year.
Market Cap
917.74M
Enterprise Value
542.74M
Revenue
396.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.60
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 917.74M, a decrease of -86.93%. That is a compound annual growth rate of -44.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2026 | 883.39M | -32.46% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cutia Therapeutics | 1.34B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.32B |
| Kintor Pharmaceutical | 1.14B |
| CANbridge Pharmaceuticals | 1.08B |
| Wuhan YZY Biopharma | 1.00B |
| Sunho Biologics | 970.43M |
| JW (Cayman) Therapeutics Co. | 815.85M |
| Brii Biosciences | 815.64M |